跳至主要内容
临床试验/NCT07825649
NCT07825649尚未招募不适用

Modelization of Early Endometrial-trophoblast Molecular Interaction

Centre Hospitalier Intercommunal Creteil1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2026年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Determine transcriptionnal and proteic signatures of endometrial-trophoblast

研究概览

简要总结

Despite significant advances in assisted reproductive technology, only 25% of in vitro fertilization (IVF) embryo transfers result in pregnancy, largely due to implantation failure. Preeclampsia complicates 2 to 5% of pregnancies, causes 76,000 maternal deaths worldwide each year, and is one of the leading causes of extreme prematurity (20% of premature births occurring before 32 weeks of gestation). The MEETMI project aims to characterize, in the laboratory, the early endometrium-trophoblast molecular interactions that determine the initial stages of human implantation and placentation. As part of routine care, patients will undergo a diagnostic hysteroscopy during which a endometrial biopsy may be performed. If the patient consents to participate in the study, an additional extended endometrial biopsy will be collected for research purposes.

详细描述

Despite significant advances in assisted reproductive technology, only 25% of in vitro fertilization (IVF) embryo transfers result in pregnancy, largely due to implantation failure.

Preeclampsia complicates 2 to 5% of pregnancies, causes 76,000 maternal deaths worldwide each year, and is one of the leading causes of extreme prematurity (20% of premature births occurring before 32 weeks of gestation). There is no curative treatment, and only delivery of the baby and placenta can cure the patient. During preeclampsia, early placental abnormalities occur in the first trimester of pregnancy, even though the initial stages of human embryo implantation (apposition, adhesion, invasion) and early placentation remain poorly understood.

The primary objective of the MEETMI project is to characterize, in the laboratory, the early endometrium-trophoblast molecular interactions that determine the initial stages of human implantation and placentation.

It is essential to collect human endometrial cells (epithelial and stromal cells) from endometrial biopsies performed as part of routine care in patients who have been previously informed and have given their consent to the research.

For the placental part, following models available in the Lecarpentier's laboratory at the Institut Cochin will be used: human trophoblast stem cells (hTSCs), placental organoids derived from first-trimester placenta .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Medical indication for a diagnostic hysteroscopy between the ages of 18 and 50
  • Comprehensive information provided prior to the hysteroscopy
  • Informed consent signed by the patient

排除标准

  • Current pregnancy
  • Age < 18 or > 50
  • Patient refusal
  • Woman under court-ordered protection
  • Not enrolled in the general social security system
  • Patient who is HIV- or HCV-positive, regardless of viral load
  • Patient whose medical history requires medication that may interfere with trophoblast biology (immunomodulators in cases of autoimmune diseases, anti-rejection drugs in transplant patients)
  • Known genetic disorder in the patient
  • Unable to understand and sign the consent form

研究组 & 干预措施

Hysteroscopy arm

Experimental

Patients will undergo a diagnostic hysteroscopy during which a endometrial biopsy may be performed. An additional extended endometrial biopsy will be collected for research purposes.

干预措施: Diagnostic hysteroscopy with endometrial biopsy (Procedure)

结局指标

主要结局

Determine transcriptionnal and proteic signatures of endometrial-trophoblast

时间窗: Day 20

Determine transcriptionnal and proteic signatures of endometrial-trophoblast

次要结局

  • Placental Penetration into the extracellular matrix(Day 20)
  • Viability of the co-culture(Day 20)
  • Development of syncytiotrophoblast: To vizualise syncytiotrophoblast development: hCG concentration in co-culture supernatant(Day 20)
  • Development of syncytiotrophoblast: sFLT1 concentration in co-culture supernatant(Day 20)
  • Development of syncytiotrophoblast: PlGF concentration in co-culture supernatant(Day 20)
  • Development of syncytiotrophoblast: Fusion index(Day 20)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验